These findings suggest that AAMP promotes metabolic reprogramming in CRC via PGK1 phosphorylation, offering a novel perspective on tumor metabolic regulation and identifying AAMP as a potential target for metabolic‐based therapy. Here, PGK1 is linked to colorectal carcinoma.